Dexamethasone eardrop with grommet placement vs intratympanic steroid injection for sudden sensorineural hearing loss: A randomized prospective clinical trial
American Journal of Otolaryngology - Head and Neck Medicine and Surgery May 04, 2020
Chang WT, Zee B, Lee HSH, et al. - In this prospective, multicentered, randomized controlled trial involving 56 patients, researchers sought to compare different means of intratympanic steroid delivery in the treatment of idiopathic sudden sensorineural hearing loss. Participants in the study were patients who fulfilled the inclusion criteria for idiopathic sudden sensorineural hearing loss who failed or were contraindicated for oral steroids. According to delivery methods, study participants were randomly divided into two groups: group A received 4 sections of intratympanic dexamethasone injection and group B received grommet placement with dexamethasone delivery followed by 3 sections of dexamethasone ear drop application. No statistical significance was observed between both groups in hearing threshold improvement. Grommet placement followed by the application of dexamethasone eardrop is a reasonable option for a patient indicated for intratympanic steroid, with lower medical cost, shorter waiting times and greater satisfaction.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries